Strengths and limitations of large databases in lung cancer radiation oncology research

被引:50
作者
Jairam, Vikram [1 ]
Park, Henry S. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, 35 Pk St, New Haven, CT 06520 USA
[2] Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA
关键词
Lung cancer; large databases; big data; radiation oncology; radiotherapy; observational; limitations; STEREOTACTIC BODY RADIOTHERAPY; STAGE-I; IMPROVED SURVIVAL; POSTOPERATIVE RADIOTHERAPY; ELDERLY-PATIENTS; UNITED-STATES; ADJUVANT CHEMOTHERAPY; PRACTICE PATTERNS; HOSPITAL VOLUME; THERAPY SBRT;
D O I
10.21037/tlcr.2019.05.06
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There has been a substantial rise in the utilization of large databases in radiation oncology research. The advantages of these datasets include a large sample size and inclusion of a diverse population of patients in a real-world setting. Such observational studies hold promise in enhancing our understanding of questions for which evidence is conflicting or absent in lung cancer radiotherapy. However, it is critical that investigators understand the strengths and limitations of large databases in order to avoid the common pitfalls that beset observational analyses. This review begins by outlining the data variables available in major registries that are used most often in observational analyses. This is followed by a discussion of the type of radiotherapy-related questions that can be addressed using such datasets, accompanied by examples from the lung cancer literature. Finally, we describe some limitations of observational research and techniques to mitigate bias and confounding. We hope that clinicians and researchers find this review helpful for designing new research studies and interpreting published analyses in the literature.
引用
收藏
页码:S172 / S183
页数:12
相关论文
共 84 条
[1]   ANALYSIS OF SURVIVAL BY TUMOR RESPONSE [J].
ANDERSON, JR ;
CAIN, KC ;
GELBER, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) :710-719
[2]  
[Anonymous], 2016, J NATL CANC I
[3]  
[Anonymous], 2019, NCCN GUID
[4]  
[Anonymous], 2019, NAT CANC DAT
[5]   Barriers to Enrollment in Non-small Cell Lung Cancer Therapeutic Clinical Trials [J].
Baggstrom, Maria Q. ;
Waqar, Saiama N. ;
Sezhiyan, Ananth K. ;
Gilstrap, Eve ;
Gao, Feng ;
Morgensztern, Daniel ;
Govindan, Ramaswamy .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) :98-102
[6]   Looking Beyond the Numbers: Highlighting the Challenges of Population-Based Studies in Cancer Research [J].
Blanchard, Pierre ;
Garden, Adam S. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) :2317-+
[7]   Using the National Cancer Database for Outcomes Research [J].
Boffa, Daniel J. ;
Rosen, Joshua E. ;
Mallin, Katherine ;
Loomis, Ashley ;
Gay, Greer ;
Palis, Bryan ;
Thoburn, Kathleen ;
Gress, Donna ;
McKellar, Daniel P. ;
Shulman, Lawrence N. ;
Facktor, Matthew A. ;
Winchester, David P. .
JAMA ONCOLOGY, 2017, 3 (12) :1722-1728
[8]   Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study [J].
Bradley, Jeffrey D. ;
Paulus, Rebecca ;
Komaki, Ritsuko ;
Masters, Gregory ;
Blumenschein, George ;
Schild, Steven ;
Bogart, Jeffrey ;
Hu, Chen ;
Forster, Kenneth ;
Magliocco, Anthony ;
Kavadi, Vivek ;
Garces, Yolanda I. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Cliff ;
Wynn, Raymond B. ;
Koprowski, Christopher ;
Meng, Joanne ;
Beitler, Jonathan ;
Gaur, Rakesh ;
Curran, Walter, Jr. ;
Choy, Hak .
LANCET ONCOLOGY, 2015, 16 (02) :187-199
[9]   Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database [J].
Brower, J. V. ;
Amini, A. ;
Chen, S. ;
Hullett, C. R. ;
Kimple, R. J. ;
Wojcieszynski, A. P. ;
Bassetti, M. ;
Witek, M. E. ;
Yu, M. ;
Harari, P. M. ;
Baschnagel, A. M. .
ANNALS OF ONCOLOGY, 2016, 27 (10) :1887-1894
[10]   Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols The SPIRIT-PRO Extension [J].
Calvert, Melanie ;
Kyte, Derek ;
Mercieca-Bebber, Rebecca ;
Slade, Anita ;
Chan, An-Wen ;
King, Madeleine T. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (05) :483-494